Variations in Gene Expression and Response to Neoadjuvant Chemotherapy in Breast Carcinoma

被引：5
|
作者：
Boidot, Romain [1 ,4 ]
Vegran, Frederique [1 ,4 ]
Soubeyrand, Marie-Sophie [2 ]
Fumoleau, Pierre [3 ]
Coudert, Bruno [3 ]
Lizard-Nacol, Sarab [1 ,4 ]
机构：
[1] IFR Sante STIC, Mol Genet Lab, Ctr Georges Francois Leclerc, F-21034 Dijon, France
[2] IFR Sante STIC, Pathol Lab, F-21034 Dijon, France
[3] IFR Sante STIC, Dept Oncol, F-21034 Dijon, France
[4] IFR Sante STIC, UMR, INSERM, U866, F-21034 Dijon, France
来源：
CANCER INVESTIGATION | 2009年 / 27卷 / 05期
关键词：
Gene expression; Apoptosis; Cell cycle; Stress; Neoadjuvant chemotherapy; Breast cancer; COMPLETE PATHOLOGICAL RESPONSE; CANCER; DOCETAXEL; PROFILES; DOXORUBICIN; EPIRUBICIN; MICROARRAYS; PREDICTION; APOPTOSIS; TUMORS;
D O I：
10.1080/07357900802298096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
In this study, we performed a screening of 266 gene expressions in breast carcinomas and carried out correlations with histological response to either FEC-100 (fluorouracil-epirubicin-cyclophosphamide; n = 16) or Tax-Epi (docetaxel-epirubicin; n = 12) treatment. Gene expression in biopsies obtained before and after one course of chemotherapy was analyzed. Expression of specific genes was significantly changed after one course of chemotherapy, particularly for Tax-Epi treatment. Comparison with histological response for both treatments revealed that only good responders exhibited changes in gene-expression profile. These results agree that expression of different genes changes in response to anthracycline-based neoadjuvant chemotherapy and show, for the first time, that response to docetaxel-based treatment implied also changes in gene-expression profile.
引用
收藏
页码：521 / 528
页数：8
相关论文
共 50 条
  • [41] Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy
    Schott, AF
    Roubidoux, MA
    Helvie, MA
    Hayes, DF
    Kleer, CG
    Newman, LA
    Pierce, LJ
    Griffith, KA
    Murray, S
    Hunt, KA
    Paramagul, C
    Baker, LH
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (03) : 231 - 238
  • [42] HER2 and response to anthracycline-based neoadjuvant chemotherapy in breast cancer
    Yao, L.
    Liu, Y.
    Li, Z.
    Ouyang, T.
    Li, J.
    Wang, T.
    Fan, Z.
    Fan, T.
    Lin, B.
    Xie, Y.
    ANNALS OF ONCOLOGY, 2011, 22 (06) : 1326 - 1331
  • [43] Dynamics of circulating microRNAs as a novel indicator of clinical response to neoadjuvant chemotherapy in breast cancer
    Zhu, Wenjie
    Liu, Mei
    Fan, Ying
    Ma, Fei
    Xu, Ningzhi
    Xu, Binghe
    CANCER MEDICINE, 2018, 7 (09): : 4420 - 4433
  • [44] Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy
    Anne F. Schott
    Marilyn A. Roubidoux
    Mark A. Helvie
    Daniel F. Hayes
    Celina G. Kleer
    Lisa A. Newman
    Lori J. Pierce
    Kent A. Griffith
    Susan Murray
    Karen A. Hunt
    Chintana Paramagul
    Laurence H. Baker
    Breast Cancer Research and Treatment, 2005, 92 : 231 - 238
  • [45] Neoadjuvant Chemotherapy of Breast Cancer: Tumor Markers as Predictors of Pathologic Response, Recurrence, and Survival
    Precht, Lisa M.
    Lowe, Kimberly A.
    Atwood, Mary
    Beatty, J. David
    BREAST JOURNAL, 2010, 16 (04): : 362 - 368
  • [46] Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: Experience of the REMAGUS 02 phase II trial
    Valet, F.
    de Cremoux, P.
    Spyratos, F.
    Servant, N.
    Dujaric, M. E.
    Gentien, D.
    Lehmann-Che, J.
    Scott, V.
    Sigal-Zafrani, B.
    Mathieu, M. C.
    Bertheau, P.
    Guinebretiere, J. M.
    Pierga, J. Y.
    Delaloge, S.
    Giacchetti, S.
    Brain, E.
    Tembo, O.
    Marty, M.
    Asselain, B.
    BREAST, 2013, 22 (06): : 1052 - 1059
  • [47] Assessment of response of neoadjuvant chemotherapy in carcinoma breast patients by high-frequency ultrasound
    Dighe, Sajika
    Shinde, Raju
    Shinde, Sangita
    Verma, Prince
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (08) : 4717 - 4722
  • [48] Apoptosis induced by neoadjuvant chemotherapy in breast cancer
    Tiezzi, DG
    De Andrade, JM
    Dos Reis, FJC
    Marana, HRC
    Ribeiro-Silva, A
    Tiezzi, MG
    Pereira, AP
    PATHOLOGY, 2006, 38 (01) : 21 - 27
  • [49] TP53 Gene Polymorphism at Codon 72 as a Response Predictor for Neoadjuvant Chemotherapy
    Vieira, Jussane Oliveira
    Pesquero, Joao Bosco
    Nazario, Afonso Celso Pinto
    BREAST CARE, 2024, 19 (02) : 96 - 105
  • [50] Expression of glutaminase 1 gene in breast cancer and its clinical significance in neoadjuvant chemotherapy
    Su, Lei
    Li, Jiayong
    Yang, Jun
    Shi, Jiong
    Yu, Decai
    Ding, Yitao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9311 - +
12345